Study links protein to hormone-resistant prostate cancer

Stat5, a cellular signaling protein activated in almost all recurrent prostate cancers resistant to hormone therapy, may be used as a target to develop drugs for the disease, researchers concluded. The study established a link between Stat5 and the hormone androgen, and plans to test the interaction to see whether it produces androgen-independent prostate tumor growth.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA